Overview Fundamentals API Earnings EOD API Sample Code Pricing

INVENTIVA S.A.(PROM.)-01 (6IV F) stock market data APIs

€2.47 -0.15(-5.7%) as of October 30, 2024
Price chart is built with Anychart

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

INVENTIVA S.A.(PROM.)-01 Financial Data Overview

2.62
2.47
-
2.62
2.47
1.448-4.205
212 M
52 362 K
19 275 K
1.013
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '6IV',
Type: 'Common Stock',
Name: 'INVENTIVA S.A.(PROM.)-01',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'FR0013233012',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

INVENTIVA S.A.(PROM.)-01 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 19 275 K
  • EBITDA -98 356 000
  • Earnings Per Share -2.06
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get INVENTIVA S.A.(PROM.)-01 Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get INVENTIVA S.A.(PROM.)-01 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com